chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pain in extremity, Platelet count decreased, Pyrexia
Clinical narrative: severe stabbing pains in upper body; low grade fever; Severe night sweats; platelets drop to 39; 2 Blood clots, one in calf, second in groin; enlarged lymph nodes; Red rash over upper body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Feb2021 10:30 (Lot number: EN6203) at the age of 72 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medication(s) included: SIMVASTATIN; ASPRIN; VITAMIN D 3. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: PAIN (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "severe stabbing pains in upper body"; PYREXIA (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "low grade fever"; NIGHT SWEATS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Severe night sweats"; PLATELET COUNT DECREASED (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "platelets drop to 39"; THROMBOSIS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "2 Blood clots, one in calf, second in groin"; LYMPHADENOPATHY (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "enlarged lymph nodes"; RASH ERYTHEMATOUS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Red rash over upper body". The events "severe stabbing pains in upper body", "low grade fever", "severe night sweats", "platelets drop to 39", "2 blood clots, one in calf, second in groin", "enlarged lymph nodes" and "red rash over upper body" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: platelet count: (11Mar2021) drop to 39. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as a result of pain, pyrexia, night sweats, platelet count decreased, thrombosis, lymphadenopathy, rash erythematous with various treatment.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Platelet count decreased, Thrombosis
Clinical narrative: severe stabbing pains in upper body; low grade fever; Severe night sweats; platelets drop to 39; 2 Blood clots, one in calf, second in groin; enlarged lymph nodes; Red rash over upper body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Feb2021 10:30 (Lot number: EN6203) at the age of 72 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medication(s) included: SIMVASTATIN; ASPRIN; VITAMIN D 3. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: PAIN (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "severe stabbing pains in upper body"; PYREXIA (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "low grade fever"; NIGHT SWEATS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Severe night sweats"; PLATELET COUNT DECREASED (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "platelets drop to 39"; THROMBOSIS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "2 Blood clots, one in calf, second in groin"; LYMPHADENOPATHY (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "enlarged lymph nodes"; RASH ERYTHEMATOUS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Red rash over upper body". The events "severe stabbing pains in upper body", "low grade fever", "severe night sweats", "platelets drop to 39", "2 blood clots, one in calf, second in groin", "enlarged lymph nodes" and "red rash over upper body" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: platelet count: (11Mar2021) drop to 39. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as a result of pain, pyrexia, night sweats, platelet count decreased, thrombosis, lymphadenopathy, rash erythematous with various treatment.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy, Night sweats, Pain, Platelet count, Platelet count decreased
Clinical narrative: severe stabbing pains in upper body; low grade fever; Severe night sweats; platelets drop to 39; 2 Blood clots, one in calf, second in groin; enlarged lymph nodes; Red rash over upper body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Feb2021 10:30 (Lot number: EN6203) at the age of 72 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medication(s) included: SIMVASTATIN; ASPRIN; VITAMIN D 3. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: PAIN (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "severe stabbing pains in upper body"; PYREXIA (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "low grade fever"; NIGHT SWEATS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Severe night sweats"; PLATELET COUNT DECREASED (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "platelets drop to 39"; THROMBOSIS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "2 Blood clots, one in calf, second in groin"; LYMPHADENOPATHY (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "enlarged lymph nodes"; RASH ERYTHEMATOUS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Red rash over upper body". The events "severe stabbing pains in upper body", "low grade fever", "severe night sweats", "platelets drop to 39", "2 blood clots, one in calf, second in groin", "enlarged lymph nodes" and "red rash over upper body" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: platelet count: (11Mar2021) drop to 39. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as a result of pain, pyrexia, night sweats, platelet count decreased, thrombosis, lymphadenopathy, rash erythematous with various treatment.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Rash erythematous, Thrombosis
Clinical narrative: severe stabbing pains in upper body; low grade fever; Severe night sweats; platelets drop to 39; 2 Blood clots, one in calf, second in groin; enlarged lymph nodes; Red rash over upper body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Feb2021 10:30 (Lot number: EN6203) at the age of 72 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medication(s) included: SIMVASTATIN; ASPRIN; VITAMIN D 3. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: PAIN (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "severe stabbing pains in upper body"; PYREXIA (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "low grade fever"; NIGHT SWEATS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Severe night sweats"; PLATELET COUNT DECREASED (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "platelets drop to 39"; THROMBOSIS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "2 Blood clots, one in calf, second in groin"; LYMPHADENOPATHY (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "enlarged lymph nodes"; RASH ERYTHEMATOUS (disability, life threatening) with onset 11Mar2021, outcome "unknown", described as "Red rash over upper body". The events "severe stabbing pains in upper body", "low grade fever", "severe night sweats", "platelets drop to 39", "2 blood clots, one in calf, second in groin", "enlarged lymph nodes" and "red rash over upper body" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: platelet count: (11Mar2021) drop to 39. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as a result of pain, pyrexia, night sweats, platelet count decreased, thrombosis, lymphadenopathy, rash erythematous with various treatment.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Headache, Impaired work ability
Clinical narrative: a CVST blood clot in my brain; vomit; headache; neck pain; migraine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0169) at the age of 35 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies Cashews and other tree nuts" (unspecified if ongoing). The patient took concomitant medications (birth control). No other vaccine in four weeks. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8733, Location of injection: Arm Left), administration date: 05Apr2021, when the patient was 35 years old, for COVID-19 immunization. No covid prior vaccination.  The following information was reported: CEREBRAL VENOUS SINUS THROMBOSIS (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "a CVST blood clot in my brain"; VOMITING (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "vomit"; HEADACHE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "headache"; NECK PAIN (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "neck pain"; MIGRAINE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "migraine". The patient was hospitalized for cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine (hospitalization duration: 2 day(s)). The events "a cvst blood clot in my brain", "vomit", "headache", "neck pain" and "migraine" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine. Clinic course included on the morning of 19May2021, patient woke up with the worst headache/neck pain she had ever had in life. This caused patient to vomit a few times before going to the ER. Once at the ER, she explained that she thought she had a migraine and vomited a couple more times. Once seen by the medical staff, patient was informed that had a CVST blood clot in brain. Patient was given Heparin and was put on oral blood thinners once discharged from the hospital, where she took them for the next 6 months.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder, Vomiting
Clinical narrative: a CVST blood clot in my brain; vomit; headache; neck pain; migraine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0169) at the age of 35 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies Cashews and other tree nuts" (unspecified if ongoing). The patient took concomitant medications (birth control). No other vaccine in four weeks. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8733, Location of injection: Arm Left), administration date: 05Apr2021, when the patient was 35 years old, for COVID-19 immunization. No covid prior vaccination.  The following information was reported: CEREBRAL VENOUS SINUS THROMBOSIS (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "a CVST blood clot in my brain"; VOMITING (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "vomit"; HEADACHE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "headache"; NECK PAIN (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "neck pain"; MIGRAINE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "migraine". The patient was hospitalized for cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine (hospitalization duration: 2 day(s)). The events "a cvst blood clot in my brain", "vomit", "headache", "neck pain" and "migraine" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine. Clinic course included on the morning of 19May2021, patient woke up with the worst headache/neck pain she had ever had in life. This caused patient to vomit a few times before going to the ER. Once at the ER, she explained that she thought she had a migraine and vomited a couple more times. Once seen by the medical staff, patient was informed that had a CVST blood clot in brain. Patient was given Heparin and was put on oral blood thinners once discharged from the hospital, where she took them for the next 6 months.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Headache, Migraine, Neck pain, SARS-CoV-2 test
Clinical narrative: a CVST blood clot in my brain; vomit; headache; neck pain; migraine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0169) at the age of 35 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies Cashews and other tree nuts" (unspecified if ongoing). The patient took concomitant medications (birth control). No other vaccine in four weeks. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8733, Location of injection: Arm Left), administration date: 05Apr2021, when the patient was 35 years old, for COVID-19 immunization. No covid prior vaccination.  The following information was reported: CEREBRAL VENOUS SINUS THROMBOSIS (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "a CVST blood clot in my brain"; VOMITING (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "vomit"; HEADACHE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "headache"; NECK PAIN (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "neck pain"; MIGRAINE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "migraine". The patient was hospitalized for cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine (hospitalization duration: 2 day(s)). The events "a cvst blood clot in my brain", "vomit", "headache", "neck pain" and "migraine" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine. Clinic course included on the morning of 19May2021, patient woke up with the worst headache/neck pain she had ever had in life. This caused patient to vomit a few times before going to the ER. Once at the ER, she explained that she thought she had a migraine and vomited a couple more times. Once seen by the medical staff, patient was informed that had a CVST blood clot in brain. Patient was given Heparin and was put on oral blood thinners once discharged from the hospital, where she took them for the next 6 months.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: a CVST blood clot in my brain; vomit; headache; neck pain; migraine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0169) at the age of 35 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies Cashews and other tree nuts" (unspecified if ongoing). The patient took concomitant medications (birth control). No other vaccine in four weeks. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8733, Location of injection: Arm Left), administration date: 05Apr2021, when the patient was 35 years old, for COVID-19 immunization. No covid prior vaccination.  The following information was reported: CEREBRAL VENOUS SINUS THROMBOSIS (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "a CVST blood clot in my brain"; VOMITING (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "vomit"; HEADACHE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "headache"; NECK PAIN (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "neck pain"; MIGRAINE (hospitalization, life threatening) with onset 19May2021, outcome "recovered", described as "migraine". The patient was hospitalized for cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine (hospitalization duration: 2 day(s)). The events "a cvst blood clot in my brain", "vomit", "headache", "neck pain" and "migraine" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of cerebral venous sinus thrombosis, vomiting, headache, neck pain, migraine. Clinic course included on the morning of 19May2021, patient woke up with the worst headache/neck pain she had ever had in life. This caused patient to vomit a few times before going to the ER. Once at the ER, she explained that she thought she had a migraine and vomited a couple more times. Once seen by the medical staff, patient was informed that had a CVST blood clot in brain. Patient was given Heparin and was put on oral blood thinners once discharged from the hospital, where she took them for the next 6 months.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Ophthalmic herpes zoster
Clinical narrative: Shingles in the left eye, face and head on the left side; Almost lost the eye. Currently some vision was lost; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 26Jul2021 18:00 (Batch/Lot number: unknown) at the age of 65 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included: LOSARTAN. Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left, Vaccine Administration Time: 06:00 PM), administration date: 05Jul2021, when the patient was 65 years old, for Covid-19 immunization. The following information was reported: HERPES ZOSTER (disability, life threatening) with onset 14Aug2021, outcome "recovered with sequelae", described as "Shingles in the left eye, face and head on the left side"; VISUAL IMPAIRMENT (disability, life threatening) with onset 14Aug2021, outcome "recovered with sequelae", described as "Almost lost the eye. Currently some vision was lost". The events "shingles in the left eye, face and head on the left side" and "almost lost the eye. currently some vision was lost" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (12Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of herpes zoster. Since the vaccination, the patient has not been tested for COVID-19. The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Visual impairment
Clinical narrative: Shingles in the left eye, face and head on the left side; Almost lost the eye. Currently some vision was lost; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 26Jul2021 18:00 (Batch/Lot number: unknown) at the age of 65 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included: LOSARTAN. Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left, Vaccine Administration Time: 06:00 PM), administration date: 05Jul2021, when the patient was 65 years old, for Covid-19 immunization. The following information was reported: HERPES ZOSTER (disability, life threatening) with onset 14Aug2021, outcome "recovered with sequelae", described as "Shingles in the left eye, face and head on the left side"; VISUAL IMPAIRMENT (disability, life threatening) with onset 14Aug2021, outcome "recovered with sequelae", described as "Almost lost the eye. Currently some vision was lost". The events "shingles in the left eye, face and head on the left side" and "almost lost the eye. currently some vision was lost" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (12Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of herpes zoster. Since the vaccination, the patient has not been tested for COVID-19. The lot number for bnt162b2 was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint injury
Clinical narrative: She needs to take steroid shots because of her bad knee; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHROPATHY (non-serious), outcome "unknown", described as "She needs to take steroid shots because of her bad knee".  Additional information: Patient was asking if that would be fine to take her steroid shot. Her second of the vaccine was scheduled on 29Mar.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: recoded event She needs to take steroid shots because of her bad knee to LLT Knee arthropathy.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthropathy
Clinical narrative: She needs to take steroid shots because of her bad knee; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHROPATHY (non-serious), outcome "unknown", described as "She needs to take steroid shots because of her bad knee".  Additional information: Patient was asking if that would be fine to take her steroid shot. Her second of the vaccine was scheduled on 29Mar.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: recoded event She needs to take steroid shots because of her bad knee to LLT Knee arthropathy.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye allergy
Clinical narrative: Allergic reaction to my right eye; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 11Mar2021 (Batch/Lot number: unknown) at the age of 35 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (administration time=09:15 AM, dose number=1, Batch/lot number: Unknown), administration date: 18Feb2021, when the patient was 34 years old, for COVID-19 immunisation. The following information was reported: EYE ALLERGY (non-serious) with onset 15Mar2021 20:00, outcome "not recovered", described as "Allergic reaction to my right eye". Therapeutic measures were not taken as a result of eye allergy.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021301140 same reporter/drug/AE with different patient
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Atrophy, Blood test normal, Magnetic resonance imaging neck, Magnetic resonance imaging normal, Muscle twitching
Clinical narrative: brisk reflexes; muscle atrophy; diagnosed with ALS; Progressive weakness; fasciculations; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 16:45 (Lot number: ER8732) at the age of 30 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Ceclor, reaction(s): "known allergies: ceclor". Vaccination history included: Bnt162b2 (dose 1, lot number: EN6199, at 16:45, in left arm), administration date: 09Mar2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: ASTHENIA (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "Progressive weakness"; MUSCLE CONTRACTIONS INVOLUNTARY (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "fasciculations"; HYPERREFLEXIA (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "brisk reflexes"; MUSCLE ATROPHY (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "muscle atrophy"; AMYOTROPHIC LATERAL SCLEROSIS (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "diagnosed with ALS". The events "progressive weakness", "fasciculations", "brisk reflexes", "muscle atrophy" and "diagnosed with als" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of asthenia, muscle contractions involuntary, hyperreflexia, muscle atrophy, amyotrophic lateral sclerosis. Clinical course: The patient experienced progressive weakness and fasciculations on 01May2021; brisk reflexes, muscle atrophy - diagnosed with ALS on 18Oct2021. All symptoms started after 2nd vaccine shot and no symptoms existed prior. The events resulted in doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. No other vaccine in four weeks and no other medications in two weeks.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Neck pain, Ultrasound joint, Ultrasound scan normal
Clinical narrative: brisk reflexes; muscle atrophy; diagnosed with ALS; Progressive weakness; fasciculations; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 16:45 (Lot number: ER8732) at the age of 30 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Ceclor, reaction(s): "known allergies: ceclor". Vaccination history included: Bnt162b2 (dose 1, lot number: EN6199, at 16:45, in left arm), administration date: 09Mar2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: ASTHENIA (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "Progressive weakness"; MUSCLE CONTRACTIONS INVOLUNTARY (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "fasciculations"; HYPERREFLEXIA (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "brisk reflexes"; MUSCLE ATROPHY (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "muscle atrophy"; AMYOTROPHIC LATERAL SCLEROSIS (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "diagnosed with ALS". The events "progressive weakness", "fasciculations", "brisk reflexes", "muscle atrophy" and "diagnosed with als" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of asthenia, muscle contractions involuntary, hyperreflexia, muscle atrophy, amyotrophic lateral sclerosis. Clinical course: The patient experienced progressive weakness and fasciculations on 01May2021; brisk reflexes, muscle atrophy - diagnosed with ALS on 18Oct2021. All symptoms started after 2nd vaccine shot and no symptoms existed prior. The events resulted in doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. No other vaccine in four weeks and no other medications in two weeks.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Amyotrophic lateral sclerosis, Asthenia, Hyperreflexia, Muscle atrophy, Muscle contractions involuntary
Clinical narrative: brisk reflexes; muscle atrophy; diagnosed with ALS; Progressive weakness; fasciculations; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 16:45 (Lot number: ER8732) at the age of 30 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Ceclor, reaction(s): "known allergies: ceclor". Vaccination history included: Bnt162b2 (dose 1, lot number: EN6199, at 16:45, in left arm), administration date: 09Mar2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: ASTHENIA (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "Progressive weakness"; MUSCLE CONTRACTIONS INVOLUNTARY (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "fasciculations"; HYPERREFLEXIA (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "brisk reflexes"; MUSCLE ATROPHY (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "muscle atrophy"; AMYOTROPHIC LATERAL SCLEROSIS (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "diagnosed with ALS". The events "progressive weakness", "fasciculations", "brisk reflexes", "muscle atrophy" and "diagnosed with als" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of asthenia, muscle contractions involuntary, hyperreflexia, muscle atrophy, amyotrophic lateral sclerosis. Clinical course: The patient experienced progressive weakness and fasciculations on 01May2021; brisk reflexes, muscle atrophy - diagnosed with ALS on 18Oct2021. All symptoms started after 2nd vaccine shot and no symptoms existed prior. The events resulted in doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. No other vaccine in four weeks and no other medications in two weeks.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccination failure
Clinical narrative: brisk reflexes; muscle atrophy; diagnosed with ALS; Progressive weakness; fasciculations; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 16:45 (Lot number: ER8732) at the age of 30 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Ceclor, reaction(s): "known allergies: ceclor". Vaccination history included: Bnt162b2 (dose 1, lot number: EN6199, at 16:45, in left arm), administration date: 09Mar2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: ASTHENIA (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "Progressive weakness"; MUSCLE CONTRACTIONS INVOLUNTARY (disability, life threatening) with onset 01May2021, outcome "not recovered", described as "fasciculations"; HYPERREFLEXIA (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "brisk reflexes"; MUSCLE ATROPHY (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "muscle atrophy"; AMYOTROPHIC LATERAL SCLEROSIS (disability, life threatening) with onset 18Oct2021, outcome "not recovered", described as "diagnosed with ALS". The events "progressive weakness", "fasciculations", "brisk reflexes", "muscle atrophy" and "diagnosed with als" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of asthenia, muscle contractions involuntary, hyperreflexia, muscle atrophy, amyotrophic lateral sclerosis. Clinical course: The patient experienced progressive weakness and fasciculations on 01May2021; brisk reflexes, muscle atrophy - diagnosed with ALS on 18Oct2021. All symptoms started after 2nd vaccine shot and no symptoms existed prior. The events resulted in doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. No other vaccine in four weeks and no other medications in two weeks.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product preparation issue
Clinical narrative: chest like it was tight; headache; chills; fever; I was given the whole vial undiluted.; I was given the whole vial undiluted.; extremely tired; drowsy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 23 year-old male patient received bnt162b2 (BNT162B2), administration date 16Oct2021 10:00 (Lot number: FF2589) at the age of 23 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OVERDOSE (non-serious), PRODUCT PREPARATION ERROR (non-serious) all with onset 16Oct2021 10:00, outcome "unknown" and all described as "I was given the whole vial undiluted."; CHEST DISCOMFORT (hospitalization) with onset 16Oct2021, outcome "unknown", described as "chest like it was tight"; HEADACHE (hospitalization) with onset 16Oct2021, outcome "unknown", described as "headache"; CHILLS (hospitalization) with onset 16Oct2021, outcome "unknown", described as "chills"; PYREXIA (hospitalization) with onset 16Oct2021, outcome "unknown", described as "fever"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "extremely tired"; SOMNOLENCE (non-serious) with onset 2021, outcome "unknown", described as "drowsy". The patient was hospitalized for chest discomfort, headache, chills, pyrexia (start date: 16Oct2021). The patient underwent the following laboratory tests and procedures: investigation: (16Oct2021) unknown results.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Headache, Investigation
Clinical narrative: chest like it was tight; headache; chills; fever; I was given the whole vial undiluted.; I was given the whole vial undiluted.; extremely tired; drowsy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 23 year-old male patient received bnt162b2 (BNT162B2), administration date 16Oct2021 10:00 (Lot number: FF2589) at the age of 23 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OVERDOSE (non-serious), PRODUCT PREPARATION ERROR (non-serious) all with onset 16Oct2021 10:00, outcome "unknown" and all described as "I was given the whole vial undiluted."; CHEST DISCOMFORT (hospitalization) with onset 16Oct2021, outcome "unknown", described as "chest like it was tight"; HEADACHE (hospitalization) with onset 16Oct2021, outcome "unknown", described as "headache"; CHILLS (hospitalization) with onset 16Oct2021, outcome "unknown", described as "chills"; PYREXIA (hospitalization) with onset 16Oct2021, outcome "unknown", described as "fever"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "extremely tired"; SOMNOLENCE (non-serious) with onset 2021, outcome "unknown", described as "drowsy". The patient was hospitalized for chest discomfort, headache, chills, pyrexia (start date: 16Oct2021). The patient underwent the following laboratory tests and procedures: investigation: (16Oct2021) unknown results.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Overdose, Product preparation error, Pyrexia, Somnolence
Clinical narrative: chest like it was tight; headache; chills; fever; I was given the whole vial undiluted.; I was given the whole vial undiluted.; extremely tired; drowsy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 23 year-old male patient received bnt162b2 (BNT162B2), administration date 16Oct2021 10:00 (Lot number: FF2589) at the age of 23 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OVERDOSE (non-serious), PRODUCT PREPARATION ERROR (non-serious) all with onset 16Oct2021 10:00, outcome "unknown" and all described as "I was given the whole vial undiluted."; CHEST DISCOMFORT (hospitalization) with onset 16Oct2021, outcome "unknown", described as "chest like it was tight"; HEADACHE (hospitalization) with onset 16Oct2021, outcome "unknown", described as "headache"; CHILLS (hospitalization) with onset 16Oct2021, outcome "unknown", described as "chills"; PYREXIA (hospitalization) with onset 16Oct2021, outcome "unknown", described as "fever"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "extremely tired"; SOMNOLENCE (non-serious) with onset 2021, outcome "unknown", described as "drowsy". The patient was hospitalized for chest discomfort, headache, chills, pyrexia (start date: 16Oct2021). The patient underwent the following laboratory tests and procedures: investigation: (16Oct2021) unknown results.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Echocardiogram, Fibrin D dimer, Laboratory test, Palpitations
Clinical narrative: Immediately upon injection I was nauseous and light headed . I was given a snack .   On August 19 I had heart palpitations, tight chest , sternum but , shortness of breath ,    On August 26 went to ER since My heart had palpable, tightness of chest , sternum hurt , body hurt given Iv and they ran test . I was sent home to wear heart monitor for two weeks  5 weeks later , my symptoms worsened I also began to experiencing  tremors, head aches , lack of sleep   I then had a heart mri and was diagnosed with Myocarditis and pericarditis on November 19, 2021 . Hospital was slow to text me , they kept denying me treatment
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac monitoring, Chest discomfort, Chest pain, Dizziness, Dyspnoea
Clinical narrative: Immediately upon injection I was nauseous and light headed . I was given a snack .   On August 19 I had heart palpitations, tight chest , sternum but , shortness of breath ,    On August 26 went to ER since My heart had palpable, tightness of chest , sternum hurt , body hurt given Iv and they ran test . I was sent home to wear heart monitor for two weeks  5 weeks later , my symptoms worsened I also began to experiencing  tremors, head aches , lack of sleep   I then had a heart mri and was diagnosed with Myocarditis and pericarditis on November 19, 2021 . Hospital was slow to text me , they kept denying me treatment
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Immediate post-injection reaction, Insomnia, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart
Clinical narrative: Immediately upon injection I was nauseous and light headed . I was given a snack .   On August 19 I had heart palpitations, tight chest , sternum but , shortness of breath ,    On August 26 went to ER since My heart had palpable, tightness of chest , sternum hurt , body hurt given Iv and they ran test . I was sent home to wear heart monitor for two weeks  5 weeks later , my symptoms worsened I also began to experiencing  tremors, head aches , lack of sleep   I then had a heart mri and was diagnosed with Myocarditis and pericarditis on November 19, 2021 . Hospital was slow to text me , they kept denying me treatment
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Nausea, Pain, Palpitations, Pericarditis
Clinical narrative: Immediately upon injection I was nauseous and light headed . I was given a snack .   On August 19 I had heart palpitations, tight chest , sternum but , shortness of breath ,    On August 26 went to ER since My heart had palpable, tightness of chest , sternum hurt , body hurt given Iv and they ran test . I was sent home to wear heart monitor for two weeks  5 weeks later , my symptoms worsened I also began to experiencing  tremors, head aches , lack of sleep   I then had a heart mri and was diagnosed with Myocarditis and pericarditis on November 19, 2021 . Hospital was slow to text me , they kept denying me treatment
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Immediately upon injection I was nauseous and light headed . I was given a snack .   On August 19 I had heart palpitations, tight chest , sternum but , shortness of breath ,    On August 26 went to ER since My heart had palpable, tightness of chest , sternum hurt , body hurt given Iv and they ran test . I was sent home to wear heart monitor for two weeks  5 weeks later , my symptoms worsened I also began to experiencing  tremors, head aches , lack of sleep   I then had a heart mri and was diagnosed with Myocarditis and pericarditis on November 19, 2021 . Hospital was slow to text me , they kept denying me treatment